A Multiple Ascending Dose Study With AZD9164 Given for 13 Days in Healthy Male and Female Subjects and in Patients With Chronic Obstructive Pulmonary Disease

Stopped Study stopped since it was considered that one of the pre-defined stopping criterion was met.

Conditions

• Healthy
• COPD

Interventions

• DRUG: AZD9164 Turbuhaler®
• DRUG: Placebo Turbuhaler®

Sponsor

AstraZeneca